StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research report sent to investors on Wednesday. The firm issued a hold rating on the stock.

TherapeuticsMD Trading Down 0.8 %

Shares of TXMD opened at $1.88 on Wednesday. TherapeuticsMD has a 12 month low of $1.84 and a 12 month high of $4.73. The stock has a fifty day moving average price of $2.19 and a 200-day moving average price of $2.28.

Institutional Trading of TherapeuticsMD

A hedge fund recently bought a new stake in TherapeuticsMD stock. ADAR1 Capital Management LLC bought a new stake in TherapeuticsMD, Inc. (NASDAQ:TXMD) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 272,160 shares of the company’s stock, valued at approximately $612,000. ADAR1 Capital Management LLC owned 2.57% of TherapeuticsMD as of its most recent SEC filing. 30.74% of the stock is currently owned by institutional investors.

About TherapeuticsMD

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.